OREX: Orexigen Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Orexigen Therapeutics, Inc.

NASDAQ:OREX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$0.19
Loss Chance
55.1%
2.75JITTA SCORE
n/a
Jitta Ranking
Pharmaceuticals
0 / 148
Healthcare
0 / 1
United States
?
4,134 / 4,151
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Allergan plc
NYSE:AGN
4.44
$193.02
8.42%
Endo International plc
NASDAQ:ENDP
2.69
$0.00
94.10%
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
5.18
$226.93
39.11%
Johnson & Johnson
NYSE:JNJ
6.93
$234.20
177.77%
Merck & Co.
NYSE:MRK
6.36
$115.44
46.65%
Jitta Factors
Growth Opportunity (20)
Recent Business Performance (60)
Financial Strength (0)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2016
Operating MarginInconsistent
Recent Business PerformanceEarning decline 38.30% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.75
n/a
2.22
210.76%
3.20
100.00%
Pharmaceuticals
4.44
8.42%
2.69
94.10%
5.18
39.11%
COMPANY DESCRIPTION
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
www.orexigen.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.